PCOS isn’t necessarily more common than it used to be, but several forces are converging to make it look that way. Broader diagnostic criteria, rising obesity rates, greater exposure to hormone-disrupting chemicals, and significantly more awareness have all pushed the number of diagnosed cases upward. The World Health Organization estimates PCOS now affects 10 to 13% of reproductive-age women globally, making it one of the most common hormonal conditions in the world.
Wider Diagnostic Criteria Tripled the Numbers
The single biggest reason PCOS appears more common today is that the medical definition expanded. Before 2003, doctors used a narrow set of criteria developed by the National Institutes of Health that required both excess androgen levels and irregular periods. In 2003, an international consensus meeting in Rotterdam, the Netherlands, broadened the definition. Under the newer criteria, a woman only needs two of three features: signs of excess androgens, irregular ovulation, or a characteristic pattern of ovarian follicles on ultrasound.
That change had a dramatic effect. In one community-based study from Iran, the prevalence of PCOS was 4.8% under the old NIH criteria and 14.1% under the Rotterdam criteria, a 2.9-fold increase. In practical terms, adopting the broader definition nearly tripled the number of women who qualified for a diagnosis. The 2023 international evidence-based guideline reaffirmed the Rotterdam approach as the standard, meaning these wider criteria are now embedded in medical practice worldwide.
The 2023 guideline also introduced a new diagnostic tool: a blood test measuring anti-Müllerian hormone (AMH), which reflects the number of small follicles on the ovaries. This can now be used in place of an ultrasound to confirm PCOS, making diagnosis easier and more accessible, particularly in primary care settings that lack imaging equipment. More accessible testing means more women get identified.
Obesity and Insulin Resistance Are Fueling Cases
PCOS and metabolic health are tightly linked. Between 44% and 70% of women with PCOS have insulin resistance, a condition where the body’s cells stop responding efficiently to insulin. When insulin levels stay chronically high, the ovaries produce more androgens (hormones like testosterone), which drives the irregular cycles, acne, and excess hair growth that define the condition. Up to 80% of women with PCOS in the United States are overweight or obese, compared with 30 to 50% in other countries.
Global obesity rates have roughly tripled since 1975. As more women carry excess weight, more women develop the insulin resistance that can trigger or worsen PCOS symptoms. This doesn’t mean weight causes PCOS on its own. Many lean women have the condition. But rising obesity rates are almost certainly pushing more women past the hormonal threshold where symptoms become noticeable and diagnosable. The relationship runs both directions, too: PCOS makes it harder to lose weight, which worsens insulin resistance, which worsens PCOS.
Hormone-Disrupting Chemicals Are Everywhere
Modern life exposes people to a growing number of synthetic chemicals that interfere with the endocrine system. Two of the most studied in relation to PCOS are BPA (found in plastics, food packaging, and receipt paper) and phthalates (found in personal care products, vinyl flooring, and food containers). These compounds mimic or block natural hormones, disrupt insulin signaling, and may trigger lasting changes to how genes are expressed.
The exposure is difficult to avoid. BPA and phthalates are detectable in the urine of the vast majority of people tested in population studies. While no one has proven these chemicals directly cause PCOS in humans, the evidence linking them to hormonal disruption and worsening of PCOS features continues to grow. Exposure during sensitive windows, particularly fetal development and puberty, appears to carry the most risk.
Prenatal Programming Before Birth
Some of the groundwork for PCOS may be laid in the womb. Experimental studies in primates show that exposing female fetuses to high levels of testosterone during a critical window of pregnancy produces PCOS-like features in adulthood, including irregular ovulation, excess androgens, and characteristic ovarian changes. The timing matters: early gestational exposure is what drives the hormonal reprogramming, not exposure later in pregnancy.
What raises androgen levels during pregnancy in the first place? Maternal stress is one pathway. Chronic stress activates the body’s stress-hormone system, which directly influences the production of sex hormones. A mother experiencing significant stress during pregnancy may inadvertently expose her developing daughter to a hormonal environment that increases PCOS risk decades later. Given that modern life involves higher rates of reported psychological stress, financial pressure, and exposure to endocrine disruptors, it’s plausible that each generation of daughters faces a slightly higher baseline risk than the last.
Greater Awareness Changes the Count
Not long ago, many women with PCOS symptoms went undiagnosed for years. Irregular periods were dismissed as stress. Acne and facial hair were treated cosmetically without anyone investigating the underlying cause. That has shifted considerably. Social media, patient advocacy, and updated clinical guidelines have all raised the profile of PCOS among both patients and doctors.
The 2023 international guideline emphasizes a structured diagnostic approach starting with clinical assessment, then blood work, then selective use of ultrasound or AMH testing. This kind of standardized pathway means fewer cases slip through the cracks. Women are also more likely to advocate for themselves. When someone searches their symptoms and finds that irregular periods combined with stubborn weight gain and hormonal acne could point to PCOS, they walk into a doctor’s office with a specific question. That alone increases the diagnosis rate without any change in the actual number of affected women.
Is PCOS Actually More Common, or Just More Visible?
The honest answer is both. Diagnostic expansion and better awareness account for a large portion of the apparent increase. If you widen the definition of a condition and then give doctors better tools to find it, you will inevitably identify more cases. Some proportion of the “rise” in PCOS is simply women who always had it finally getting a name for their symptoms.
But environmental and metabolic shifts are real, too. Populations are heavier than they were 40 years ago, insulin resistance is more prevalent, and chemical exposures are pervasive in ways they weren’t a generation ago. Prenatal stress and its hormonal consequences may be compounding the problem across generations. These factors suggest that the true prevalence of PCOS, not just the diagnosed prevalence, is likely climbing as well. The condition sits at the intersection of genetics, metabolism, and environment, and all three of those inputs have shifted in ways that favor its development.